Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)

Authors:

Abstract
Iron‐deficiency anemia is a potent stimulator of the phosphaturic hormone FGF23, and anemia, elevated FGF23, and serum phosphate are all significant risk factors for chronic kidney disease (CKD) pati...
Funding Information
  • National Heart, Lung, and Blood Institute (R01‐HL145528, T32‐HL007910)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (F32‐AR065389, R21‐AR059278)
  • National Institute of Diabetes and Digestive and Kidney Diseases (F31‐DK122679, R01‐DK112958)

This publication has 31 references indexed in Scilit: